$ Value
$1.9M
Shares
66,363
Price
$28
Filed
Mar 4
Insider
Name
Shaikhly Samira
Title
Chief People Officer
CIK
0002040363
Roles
Transaction Details
Transaction Date
2026-03-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
793
Footnotes
Includes 793 shares acquired under the Septerna, Inc. 2024 Employee Stock Purchase Plan on October 31, 2025 in a transaction that was exempt under Rule 16b-3(c). | This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 31, 2025. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.90 to $27.89. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $27.90 to $28.70. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. | 25% of the shares underlying this option vested on February 1, 2024, with the remainder vesting in thirty-six substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service the Issuer on each such vesting date. | 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
Filing Info
Shaikhly Samira's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | SEPN | M | $83K |
| 2026-03-02 | SEPN | M | $32K |
| 2026-03-02 | SEPN | M | $14K |
| 2026-03-02 | SEPN | ▼ | $112K |
| 2026-03-02 | SEPN | ▼ | $1.9M |
| 2026-03-02 | SEPN | M | $0 |
| 2026-03-02 | SEPN | M | $0 |
| 2026-03-02 | SEPN | M | $0 |
| 2026-02-06 | SEPN | A | $0 |
| 2025-08-07 | SEPN | A | $0 |
Other Insiders at SEPN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Labrucherie Gil M
Chief Financial Officer
|
— | — | 2026-02-06 |
|
Bhatt Elizabeth
President and COO
|
— | $213K | 2026-04-15 |
|
Wilson Mark Andrew
Chief Legal Officer
|
— | — | 2026-02-06 |
|
Kim Jae B.
Chief Medical Officer
|
— | — | 2026-02-06 |
|
Long Daniel D.
SVP, Drug Discovery
|
— | — | 2026-02-06 |
|
Klein Uwe
SVP, Biological Sciences
|
— | — | 2026-02-06 |
|
Shaikhly Samira
Chief People Officer
|
— | $112K | 2026-03-02 |
|
Finer Jeffrey
Chief Executive Officer
|
— | — | 2026-02-06 |